Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs Vishay Intertechnology Inc. Common Stock (VSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs Vishay Intertechnology Inc. Common Stock — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.08B), while Vishay Intertechnology Inc. Common Stock trades at $27.88 (market cap $4.43B). The key difference: Oruka Therapeutics Inc. Common Stock and Vishay Intertechnology Inc. Common Stock are close in size by market cap, and Vishay Intertechnology Inc. Common Stock pays a 1.38% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Vishay Intertechnology Inc. Common Stock for 6 Days on average.
| ORKA | VSH | |
|---|---|---|
Market Cap | $5.08B | $4.43B |
Volume | 685,276 | 3,881,013 |
Sector | Health | Technology |
52-Week High | $113.08 | $64.90 |
52-Week Low | $26.19 | $11.82 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $4.21B | $4.23B |
Dividend Yield | — | 1.38% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Vishay Intertechnology (VSH) trades at $31.76, down 0.84% with bearish technical signals despite recent earnings beats. The stock shows mixed fundamentals with a high P/E ratio of 158.8 but improving profitability trends, with net income projected to turn positive in 2026. Recent news highlights the company's focus on EV and AI infrastructure solutions, positioning it for growth in key technology markets.
While analyst consensus remains positive with a $43 price target, investors face valuation concerns and execution risks. The technical outlook suggests near-term pressure, but long-term growth potential exists if the company can capitalize on automotive and AI semiconductor demand while improving profit margins from current low levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About Vishay Intertechnology Inc. Common Stock
Vishay Intertechnology manufactures discrete semiconductors and passive electronic components. Its products include diodes, MOSFETs, resistors, capacitors, and sensors.
Read more on VSH →
